Barry Kyle

Provincial Clinical Lead - Biochemistry & Assistant Professor

University of Saskatchewan

Canada

Research Interests

Explore related searches

Professors in Canada

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Barry Kyle is the Provincial Clinical Lead - Biochemistry and an Assistant Professor at the University of Saskatchewan, Canada. His research areas include biochemistry test capacity during the COVID-19 pandemic, glucose meter accuracy in neonatal hypoglycemia detection, and biomarkers in inflammatory bowel disease. He has contributed to various publications focusing on clinical impacts and the physiological roles of calcium-activated potassium channels.

Articles (10)

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (1)

Maria Sancho

Profesor Ayudante Doctor

Universidad Complutense de Madrid

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Barry Kyle

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

The Large-Conductance, Calcium-Activated Potassium Channel: A Big Key Regulator of Cell Physiology.

Clinical false positives resulting from recent intravenous immunoglobulin therapy: case report

The clinical effect of glucose meter selection upon the detection of neonatal hypoglycemia

Fecal Calprotectin, CRP and Leucocytes in IBD Patients: Comparison of Biomarkers With Biopsy Results

COVID-19 Pandemic Planning: Simulation Models to Predict Biochemistry Test Capacity for Patient Surges.

Contribution of Glucose Meter Error to Misclassification of Neonatal Glycemic Status.

The Impact of Sample Degradation on Hemoglobinopathy Investigations: A Cautionary Tale.

KCa channel activation normalizes endothelial function in Type 2 Diabetic resistance arteries by improving intracellular Ca<sup>2+</sup> mobilization.

Alpha-1-antitrypsin molecular testing in Canada: A seven year, multi-centre comparison.

NullCanada: A novel α1-antitrypsin allele with in cis variants Glu366Lys and Ile100Asn.

Collaborators (1)

Maria Sancho

Make your next move.